Now showing items 31-40 of 45
Treatment-related toxicities in tumor-bearing cats treated with temozolomide alone or in combination with doxorubicin: a pilot assessment
(Sage Publications Ltd, 2012-08-01)
NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-lambda B signaling
(Impact Journals Llc, 2016-05-31)
Use of an image-guided robotic radiosurgery system for the treatment of canine nonlymphomatous nasal tumors
An image-guided robotic stereotactic radiosurgery (SRS) system can be used to deliver curative-intent radiation in either single fraction or hypofractionated doses. Medical records for 19 dogs with nonlymphomatous nasal ...
Evaluation and comparison of outcomes in dogs with periarticular and nonperiarticular histiocytic sarcoma
(Amer Veterinary Medical Assoc, 2011-07-01)
Objective—To evaluate and compare the outcomes of dogs with periarticular histiocytic sarcoma (PAHS) and histiocytic sarcoma of other anatomic locations (non-PAHS) and identify factors associated with outcome for dogs with ...
Canine tonsillar squamous cell carcinoma - a multi-centre retrospective review of 44 clinical cases
Evaluation of ifosfamide salvage therapy formetastatic canine osteosarcoma
Effect of a single intra-articular injection of bupivacaine on synovial fluid prostaglandin E2 concentrations in normal canine stifles
Abstract Objective To identify if synovial fluid prostaglandin E2 increases in response to a single intra-articular dose of bupivacaine in the normal canine stifle. ...
Recommended Guidelines for the Conduct and Evaluation of Prognostic Studies in Veterinary Oncology
(Sage Publications Inc, 2011-01-01)
Treatment with DAV for Advanced-Stage Hemangiosarcoma in Dogs
(Amer Animal Hospital Assoc, 2011-05-01)
Safety of concurrent administration of dexrazoxane and doxorubicin in the canine cancer patient
(Wiley-Blackwell Publishing, Inc, 2010-12-01)